Milestone Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $-868 | $-868 | $0 |
Gross Profit | -26 | -28 | -1,400 | -23 |
EBITDA | -9,701 | -10,516 | -13,342 | -14,216 |
EBIT | -9,727 | -10,544 | -13,385 | -14,239 |
Net Income | -9,363 | -10,354 | -13,611 | -15,081 |
Net Change In Cash | 0 | -868 | -868 | 0 |
Free Cash Flow | -5,953 | -8,934 | -9,251 | -12,178 |
Cash | 13,262 | 10,131 | 13,760 | 9,879 |
Basic Shares | 66,165 | 50,155 | 33,483 | 42,973 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,000 | $5,000 | $15,000 | $15,000 |
Gross Profit | 402 | 5,000 | 15,000 | -376 |
EBITDA | -60,812 | -59,553 | -42,980 | -50,613 |
EBIT | -61,410 | -59,642 | -43,342 | -50,989 |
Net Income | -59,685 | -57,134 | -42,633 | -49,967 |
Net Change In Cash | 1,000 | 5,000 | 15,000 | 15,000 |
Cost of Revenue | 41,831 | -47,508 | ||
Free Cash Flow | -46,536 | -52,741 | -33,224 | -50,732 |
Cash | 13,760 | 7,636 | 114,141 | 72,310 |
Basic Shares | 42,955 | 42,450 | 41,833 | 29,344 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.14 |
2024-03-31 | -$0.21 |
2023-12-31 | -$0.32 |
2023-09-30 | -$0.35 |
